Immuron Ltd.   Report issue

For profit Phase 2
Founded: Armdale Australia (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2012
NCT01466894
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Immuron Ltd.